Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global transradial access market and estimate the size of other dependent submarkets. Various secondary sources such as World Health Organization (WHO), Central Intelligence Agency (CIA), Centers for Disease Control and Prevention (CDC), European Renal Care Providers Association (ERCPA), Society for Cardiovascular Angiography and Interventions (SCAI), American Heart Association (AHA), Canadian Association of Interventional Cardiology (CAIC), Asian Pacific Society of Interventional Cardiology (APSIC), American College of Cardiology, directories, industry journals, databases, and annual reports of companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
[142 Pages Report] The global transradial access market is projected to reach USD 2.18 Billion by 2022 from USD 1.44 Billion in 2016, at a CAGR of 7.5% during the forecast period. Base year considered for the report is 2016 and the forecast period is 2017–2022.
Get PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14566259
Company Information
Detailed analysis and profiling of additional market players (Up to 5)
The transradial access market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The increasing prevalence of obesity, growing preference for interventional procedures using radial artery access, technological advancements, rising prevalence of lifestyle diseases, and increasing number of chemotherapy procedures globally are factors expected to drive the market.
By product, transradial access market is segmented into catheters, guidewires, sheaths and sheath introducers, and accessories (needles and cannulas). Catheters market is expected to grow with highest growth rate owing to factors such as the increasing incidence of lifestyle-related diseases such as CVD, obesity, and diabetes and the growing number of interventional and angiography procedures.
On the basis of application, the transradial access market is segmented as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. Drug administration market is estimated to grow with highest CAGR owing to factors such as high usage of radial access devices for drug administration for treatment of infections and cancer.
The transradial access market is segmented on the basis of end users into hospitals, clinics and ambulatory care centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and Home Healthcare agencies). The hospitals segment is expected to grow with highest growth rate owing to the large number of transradial procedures performed in hospital settings.
Transradial Access Market
By geography, transradial access market is segmented as North America, Europe, Asia Pacific and RoW. North America, market is likely to grow with highest growth rate owing to factors such as growing prevalence of CVDs, rising number of conferences and workshops, the large number of cancer patients, and increase in research and clinical trials for vascular access devices
Factors such as a dearth of skilled professionals and the risks associated with radial access devices are anticipated to limit the growth of the market to a certain extent.
Get a Sample of Vascular Graft Market
https://www.marketsandmarkets.com/requestsampleNew.asp?id=14566259
Key Market Players
The prominent players in the Transradial Access Market include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).